![Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial]()
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trialSchwameis, Michael; Kündig, Thomas; Huber, Gustave; von Bidder, Luzi; Meinel, Lorenz; Weisser, Roland; Aberer, Elisabeth; Härter, Georg; Weinke, Thomas; Jelinek, Tomas; Fätkenheuer, Gerd; Wollina, Uwe; Burchard, Gerd-Dieter; Aschoff, Roland; Nischik, Ruth; Sattler, Gerhard; Popp, Georg; Lotte, Wolfgang; Wiechert, Dirk; Eder, Gerald; Maus, Olga; Staubach-Renz, Petra; Gräfe, Andrea; Geigenberger, Veronika; Naudts, Ingomar; Sebastian, Michael; Reider, Norbert; Weber, Ridwan; Heckmann, Marc; Reisinger, Emil C; Klein, Georg; Wantzen, Johannes; Jilma, Bernd · The Lancet Infectious Diseases · 2017